Linqto Soars to 500K Users in Over 110 Countries
Platform continues to democratize access to private markets with over
Linqto strives to provide a superior user experience that continuously innovates and enhances offerings to meet the needs of customers in this rapidly evolving investment environment. In response to customer feedback, earlier this year, Linqto added a new functionality that provides true liquidity to private markets by allowing users to buy and sell investments in companies on the platform prior to a liquidity event. The company also rebranded to align with its mission more closely and now non-accredited investors have the ability to invest in select companies on the platform at a more accessible entry point of
"We are proud to continue to democratize access to the private markets, as these types of investments are historically very lucrative but difficult to access for the public," said
Since its inception, Linqto has provided investors on the platform access to some of the world's leading unicorns and private companies, including Ripple, Circle, Brex, Epic Games, Acorns and more. Accredited investors gain early access to these companies for a minimum investment of
To learn more about Linqto and its services, visit www.linqto.com.
About Linqto
Linqto is a leading global financial technology investment platform allowing accredited investors to identify, evaluate, invest in, and make liquid investments in the world's leading unicorns and private companies. Accredited investors worldwide have trusted Linqto to make over US
IMPORTANT LEGAL NOTICE AND DISCLOSURES: The information contained herein is education in nature and does it constitute a solicitation or an offer to buy or sell any security or other financial instrument.
View original content to download multimedia:https://www.prnewswire.com/news-releases/linqto-soars-to-500k-users-in-over-110-countries-302012374.html
SOURCE Linqto
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leo Cancer Care Brings Into Clinical Use an Upright Radiotherapy Platform Cleared for Use With Any Radiation Beam
- 2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206
- Glen Elgin Investments Builds a Capital Growth Model Around Client Alignment
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share